HIV / AIDS in the News

ACTG launches critical study evaluating hormone therapy for women living with HIV in the menopause transition - European AIDS Treatment Group

 

FDA Approves Doravirine/Islatravir, a First-in-Class Two-Drug HIV Regimen - Contagion Live

 

HIV cases on the rise in Chicago: Doctor offers insight on how to slow the trend - WGN-TV

 

Religious Exemption Laws Are Leading to Drops in HIV Testing - U.S. News & World Report

 

Survivors: Portraits of Resilience Personal Accounts of the AIDS Crisis - Artlyst

 

National HIV advocacy group's CEO rejects claims of crisis - Advocate.com

 

'12,000 Floridians cannot wait': New campaign demands permanent funding fix for HIV drug program - WLRN

 

Our anti-HIV jab will be rolled out in 6 weeks. But funding cuts hollowed out the system needed to deliver it - Bhekisisa

 

For Young People, Now’s the Time to Talk About HIV - Word In Black

 

Radio campaign on preventing mother-to-child HIV transmission set for launch - The Nation Newspaper

 

Recon: FDA approves Merck’s HIV pill combo; Moderna gets EU nod for combined flu, COVID shot in older patients - RAPS.org

 

Florida International University: HIV disrupts lung "clock," raising COPD and emphysema risk - European AIDS Treatment Group

 

University of Gothenburg: Early immune responses linked to protective HIV antibodies - European AIDS Treatment Group

 

US FDA approves Merck's pill combo to treat HIV infection - Reuters

 

FDA Approves Once-Daily HIV Regimen Combining Doravirine and Islatravir - Pharmacy Times

 

Gladstone Institutes: Scientists map how HIV hijacks human cells — and how cells can fight back - European AIDS Treatment Group

 

Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso - Fierce Pharma

 

[Press release] FDA approves Merck’s once-daily IDVYNSO™ (doravirine/islatravir) - European AIDS Treatment Group

 

Merck (MRK) Gains FDA Approval for New HIV Treatment Idvynso - GuruFocus

 

FDA approves Merck’s Idvynso for HIV-1 treatment switch - Investing.com

 

Two-Drug HIV Regimen Gains FDA Approval - Conexiant

 

The Incredible Nine (or More?) Lives of Sean Strub, 67—Politico, Activist, Magazine Founder, Hotel Owner, Smalltown Mayor, Etc. - The Caftan Chronicles

 

Why Rutgers dean argues we need to 'humanize' public health to improve outcomes - Healthbeat

 

One in three young women in Africa have never tested for HIV – new study shows where the gaps lie - Modern Ghana

 

FDA clears Merck & Co.'s two-drug HIV pill Idvynso - FirstWord Pharma

 

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Bay to Bay News

 

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Merck.com

 

FDA approves once-daily HIV pill from Merck - Endpoints News

 

US FDA approves Merck’s combination HIV treatment By Reuters - Investing.com

 

US FDA approves Merck's combination HIV treatment - Yahoo